{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T14:31:16Z","timestamp":1792161076545,"version":"4.4.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,1,26]]},"DOI":"10.7759\/cureus.53009","type":"journal-article","created":{"date-parts":[[2024,1,27]],"date-time":"2024-01-27T00:28:20Z","timestamp":1706315300000},"source":"Crossref","is-referenced-by-count":3,"title":["Alpha-2 Agonists in Children and Adolescents With Post-traumatic Stress Disorder: A Systematic Review"],"prefix":"10.7759","author":[{"given":"Amit","family":"Jagtiani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raghu","family":"Gandhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akshat","family":"Banga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacquetta","family":"Blacker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riecha","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhaswanth","family":"Bollu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Kashyap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1093\/jpepsy\/jss101","article-title":"Early life trauma exposure and stress sensitivity in young children","volume":"38","author":"Grasso DJ","year":"2013","unstructured":"Grasso DJ, Ford JD, Briggs-Gowan MJ. Early life trauma exposure and stress sensitivity in young children. J Pediatr Psychol. 2013, 38:94-103. 10.1093\/jpepsy\/jss101","journal-title":"J Pediatr Psychol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaac.2013.05.011","article-title":"Trauma exposure and posttraumatic stress disorder in a national sample of adolescents","volume":"52","author":"McLaughlin KA","year":"2013","unstructured":"McLaughlin KA, Koenen KC, Hill ED, Petukhova M, Sampson NA, Zaslavsky AM, Kessler RC. Trauma exposure and posttraumatic stress disorder in a national sample of adolescents. J Am Acad Child Adolesc Psychiatry. 2013, 52:815-30. 10.1016\/j.jaac.2013.05.011","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1093\/jurban\/jth138","article-title":"Trauma exposure and posttraumatic stress disorder: a study of youths in urban America","volume":"81","author":"Breslau N","year":"2004","unstructured":"Breslau N, Wilcox HC, Storr CL, Lucia VC, Anthony JC. Trauma exposure and posttraumatic stress disorder: a study of youths in urban America. J Urban Health. 2004, 81:530-44. 10.1093\/jurban\/jth138","journal-title":"J Urban Health"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.37301","article-title":"Parents\u2019 awareness of bullying involvement in relation to physician practices: implications for practice modifications","volume":"15","author":"Nagi T","year":"2023","unstructured":"Nagi T, Somvanshi S, Balasubramania Pandian GSD, Mohan S, Seegobin SA, Altonen B. Parents\u2019 awareness of bullying involvement in relation to physician practices: implications for practice modifications. Cureus. 2023, 15:10.7759\/cureus.37301","journal-title":"Cureus"},{"key":"ref5","unstructured":"Diagnostic and Statistical Manual of Mental Disorders (5th ed.). https.\/\/doi.org\/10.1176\/appi.books.9780890425596."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.08m04783","article-title":"Complex trauma among psychiatrically impaired children: a cross-sectional, chart-review study","volume":"70","author":"Ford JD","year":"2009","unstructured":"Ford JD, Connor DF, Hawke J. Complex trauma among psychiatrically impaired children: a cross-sectional, chart-review study. J Clin Psychiatry. 2009, 70:1155-63. 10.4088\/JCP.08m04783","journal-title":"J Clin Psychiatry"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s11920-008-0019-0","article-title":"Post-traumatic stress disorder and its treatment in children and adolescents","volume":"10","author":"Najjar F","year":"2008","unstructured":"Najjar F, Weller RA, Weisbrot J, Weller EB. Post-traumatic stress disorder and its treatment in children and adolescents. Curr Psychiatry Rep. 2008, 10:104-8. 10.1007\/s11920-008-0019-0","journal-title":"Curr Psychiatry Rep"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1001\/archpediatrics.2010.247","article-title":"Community treatment of posttraumatic stress disorder for children exposed to intimate partner violence: a randomized controlled trial","volume":"165","author":"Cohen JA","year":"2011","unstructured":"Cohen JA, Mannarino AP, Iyengar S. Community treatment of posttraumatic stress disorder for children exposed to intimate partner violence: a randomized controlled trial. Arch Pediatr Adolesc Med. 2011, 165:16-21. 10.1001\/archpediatrics.2010.247","journal-title":"Arch Pediatr Adolesc Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1080\/20008198.2020.1802920","article-title":"Pharmacological therapy for post-traumatic stress disorder: a systematic review and meta-analysis of monotherapy, augmentation and head-to-head approaches","volume":"12","author":"Hoskins MD","year":"2021","unstructured":"Hoskins MD, Bridges J, Sinnerton R, et al.. Pharmacological therapy for post-traumatic stress disorder: a systematic review and meta-analysis of monotherapy, augmentation and head-to-head approaches. Eur J Psychotraumatol. 2021, 12:10.1080\/20008198.2020.1802920","journal-title":"Eur J Psychotraumatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.12r07757","article-title":"Patient preference for psychological vs pharmacologic treatment of psychiatric disorders: a meta-analytic review","volume":"74","author":"McHugh RK","year":"2013","unstructured":"McHugh RK, Whitton SW, Peckham AD, Welge JA, Otto MW. Patient preference for psychological vs pharmacologic treatment of psychiatric disorders: a meta-analytic review. J Clin Psychiatry. 2013, 74:595-602. 10.4088\/JCP.12r07757","journal-title":"J Clin Psychiatry"},{"key":"ref11","article-title":"Practice parameter for the assessment and treatment of children and adolescents with posttraumatic stress disorder","volume":"49","author":"Cohen JA","year":"2010","unstructured":"Cohen JA, Bukstein O, Walter H, et al.. Practice parameter for the assessment and treatment of children and adolescents with posttraumatic stress disorder. J Am Acad Child Adolesc Psychiatry. 2010, 49:414-30.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/s1056-4993(02)00102-5","article-title":"Pharmacologic treatment approaches for children and adolescents with posttraumatic stress disorder","volume":"12","author":"Donnelly CL","year":"2003","unstructured":"Donnelly CL. Pharmacologic treatment approaches for children and adolescents with posttraumatic stress disorder. Child Adolesc Psychiatr Clin N Am. 2003, 12:251-69. 10.1016\/s1056-4993(02)00102-5","journal-title":"Child Adolesc Psychiatr Clin N Am"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2009.0115","article-title":"Sertraline treatment of children and adolescents with posttraumatic stress disorder: a double-blind, placebo-controlled trial","volume":"20","author":"Robb AS","year":"2010","unstructured":"Robb AS, Cueva JE, Sporn J, Yang R, Vanderburg DG. Sertraline treatment of children and adolescents with posttraumatic stress disorder: a double-blind, placebo-controlled trial. J Child Adolesc Psychopharmacol. 2010, 20:463-71. 10.1089\/cap.2009.0115","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.7573\/dic.212286","article-title":"Alpha-2 receptor agonists for the treatment of posttraumatic stress disorder","volume":"4","author":"Belkin MR","year":"2015","unstructured":"Belkin MR, Schwartz TL. Alpha-2 receptor agonists for the treatment of posttraumatic stress disorder. Drugs Context. 2015, 4:10.7573\/dic.212286","journal-title":"Drugs Context"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.148.6.810b","article-title":"The clonidine test in posttraumatic stress disorder","volume":"148","author":"Hansenne M","year":"1991","unstructured":"Hansenne M, Pitchot W, Ansseau M. The clonidine test in posttraumatic stress disorder. Am J Psychiatry. 1991, 148:810-1. 10.1176\/ajp.148.6.810b","journal-title":"Am J Psychiatry"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2007.02.008","article-title":"The natural history of neuroendocrine changes in pediatric posttraumatic stress disorder (PTSD) after motor vehicle accidents: progressive divergence of noradrenaline and cortisol concentrations over time","volume":"62","author":"Pervanidou P","year":"2007","unstructured":"Pervanidou P, Kolaitis G, Charitaki S, et al.. The natural history of neuroendocrine changes in pediatric posttraumatic stress disorder (PTSD) after motor vehicle accidents: progressive divergence of noradrenaline and cortisol concentrations over time. Biol Psychiatry. 2007, 62:1095-102. 10.1016\/j.biopsych.2007.02.008","journal-title":"Biol Psychiatry"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/da.20292","article-title":"Noradrenergic dysfunction and the psychopharmacology of posttraumatic stress disorder","volume":"25","author":"Strawn JR","year":"2008","unstructured":"Strawn JR, Geracioti TD Jr. Noradrenergic dysfunction and the psychopharmacology of posttraumatic stress disorder. Depress Anxiety. 2008, 25:260-71. 10.1002\/da.20292","journal-title":"Depress Anxiety"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.nlm.2020.107327","article-title":"Guanfacine's mechanism of action in treating prefrontal cortical disorders: successful translation across species","volume":"176","author":"Arnsten AFT","year":"2020","unstructured":"Arnsten AFT. Guanfacine's mechanism of action in treating prefrontal cortical disorders: successful translation across species. Neurobiol Learn Mem. 2020, 176:10.1016\/j.nlm.2020.107327","journal-title":"Neurobiol Learn Mem"},{"key":"ref19","article-title":"Guanfacine for the treatment of cognitive disorders: a century of discoveries at Yale","volume":"85","author":"Arnsten AFT","year":"2012","unstructured":"Arnsten AFT, Jin LE. Guanfacine for the treatment of cognitive disorders: a century of discoveries at Yale. Yale J Biol Med. 2012, 85:45-58.","journal-title":"Yale J Biol Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/5251406","article-title":"Clonidine use for the treatment of nightmares in posttraumatic stress disorder","volume":"2022","author":"Bange JS","year":"2022","unstructured":"Bange JS, Melvin KE. Clonidine use for the treatment of nightmares in posttraumatic stress disorder. Case Rep Psychiatry. 2022, 2022:10.1155\/2022\/5251406","journal-title":"Case Rep Psychiatry"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.2190\/PM.44.2.g","article-title":"The use of clonidine in the treatment of nightmares among patients with co-morbid PTSD and traumatic brain injury","volume":"44","author":"Alao A","year":"2012","unstructured":"Alao A, Selvarajah J, Razi S. The use of clonidine in the treatment of nightmares among patients with co-morbid PTSD and traumatic brain injury. Int J Psychiatry Med. 2012, 44:165-9. 10.2190\/PM.44.2.g","journal-title":"Int J Psychiatry Med"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2006.0098","article-title":"Alpha-2 adrenergic receptor agonists for the treatment of attention-deficit\/hyperactivity disorder: emerging concepts from new data","volume":"17","author":"Arnsten AF","year":"2007","unstructured":"Arnsten AF, Scahill L, Findling RL. Alpha-2 adrenergic receptor agonists for the treatment of attention-deficit\/hyperactivity disorder: emerging concepts from new data. J Child Adolesc Psychopharmacol. 2007, 17:393-406. 10.1089\/cap.2006.0098","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.4088\/PCC.16r01943","article-title":"Efficacy of prazosin in posttraumatic stress disorder: a systematic review and meta-analysis","volume":"18","author":"Singh B","year":"2016","unstructured":"Singh B, Hughes AJ, Mehta G, Erwin PJ, Parsaik AK. Efficacy of prazosin in posttraumatic stress disorder: a systematic review and meta-analysis. Prim Care Companion CNS Disord. 2016, 18:10.4088\/PCC.16r01943","journal-title":"Prim Care Companion CNS Disord"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1097\/YCO.0b013e32835b2c01","article-title":"Treatment of posttraumatic stress disorder in children and adolescents","volume":"26","author":"Smith P","year":"2013","unstructured":"Smith P, Perrin S, Dalgleish T, Meiser-Stedman R, Clark DM, Yule W. Treatment of posttraumatic stress disorder in children and adolescents. Curr Opin Psychiatry. 2013, 26:66-72. 10.1097\/YCO.0b013e32835b2c01","journal-title":"Curr Opin Psychiatry"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.09r05446blu","article-title":"Psychopharmacologic treatment of posttraumatic stress disorder in children and adolescents: a review","volume":"71","author":"Strawn JR","year":"2010","unstructured":"Strawn JR, Keeshin BR, DelBello MP, Geracioti TD Jr, Putnam FW. Psychopharmacologic treatment of posttraumatic stress disorder in children and adolescents: a review. J Clin Psychiatry. 2010, 71:932-41. 10.4088\/JCP.09r05446blu","journal-title":"J Clin Psychiatry"},{"key":"ref26","unstructured":"Study quality assessment tools. (2013). Accessed. 07\/10\/2023: https:\/\/www.nhlbi.nih.gov\/health-topics\/study-quality-assessment-tools."},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2020.29186.bjc","article-title":"Guanfacine as a treatment for posttraumatic stress disorder in an adolescent female","volume":"30","author":"Anderson J","year":"2020","unstructured":"Anderson J, Wang C, Zaidi A, Rice T, Coffey BJ. Guanfacine as a treatment for posttraumatic stress disorder in an adolescent female. J Child Adolesc Psychopharmacol. 2020, 30:398-401. 10.1089\/cap.2020.29186.bjc","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2012.0119","article-title":"An open-label study of guanfacine extended release for traumatic stress related symptoms in children and adolescents","volume":"23","author":"Connor DF","year":"2013","unstructured":"Connor DF, Grasso DJ, Slivinsky MD, Pearson GS, Banga A. An open-label study of guanfacine extended release for traumatic stress related symptoms in children and adolescents. J Child Adolesc Psychopharmacol. 2013, 23:244-51. 10.1089\/cap.2012.0119","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2008.1863","article-title":"Postraumatic stress disorder and reactive attachment disorder: outcome in an adolescent","volume":"18","author":"Lyon GJ","year":"2008","unstructured":"Lyon GJ, Coffey B, Silva R. Postraumatic stress disorder and reactive attachment disorder: outcome in an adolescent. J Child Adolesc Psychopharmacol. 2008, 18:641-6. 10.1089\/cap.2008.1863","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2022.29221.bjc","article-title":"Psychopharmacological strategies employing guanfacine in an adolescent girl with postural orthostatic tachycardia syndrome and severe posttraumatic stress disorder","volume":"32","author":"Wu S","year":"2022","unstructured":"Wu S, Morgenstern A, Rice T, Coffey B. Psychopharmacological strategies employing guanfacine in an adolescent girl with postural orthostatic tachycardia syndrome and severe posttraumatic stress disorder. J Child Adolesc Psychopharmacol. 2022, 32:244-8. 10.1089\/cap.2022.29221.bjc","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1089\/10445460152595649","article-title":"Anterior cingulate N-acetylaspartate\/creatine ratios during clonidine treatment in a maltreated child with posttraumatic stress disorder","volume":"11","author":"De Bellis MD","year":"2001","unstructured":"De Bellis MD, Keshavan MS, Harenski KA. Anterior cingulate N-acetylaspartate\/creatine ratios during clonidine treatment in a maltreated child with posttraumatic stress disorder. J Child Adolesc Psychopharmacol. 2001, 11:311-16. 10.1089\/10445460152595649","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1097\/00004583-199609000-00022","article-title":"Clonidine for posttraumatic stress disorder in preschool children","volume":"35","author":"Harmon RJ","year":"1996","unstructured":"Harmon RJ, Riggs PD. Clonidine for posttraumatic stress disorder in preschool children. J Am Acad Child Adolesc Psychiatry. 1996, 35:1247-9. 10.1097\/00004583-199609000-00022","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"ref33","article-title":"Neurobiological sequelae of childhood trauma: PTSD in children","author":"Perry BD","year":"1994","unstructured":"Perry BD. Neurobiological sequelae of childhood trauma: PTSD in children. Catecholamine Function in Posttraumatic Stress Disorder: Emerging Concepts. American Psychiatric Association, 1994. 233-55."},{"key":"ref34","article-title":"The use of clonidine in post-traumatic stress disorder","volume":"91","author":"Porter DM","year":"1999","unstructured":"Porter DM, Bell CC. The use of clonidine in post-traumatic stress disorder. J Natl Med Assoc. 1999, 91:475-7.","journal-title":"J Natl Med Assoc"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1093\/ajhp\/zxz021","article-title":"Transdermal clonidine for mitigating posttraumatic stress disorder in an adolescent","volume":"76","author":"Ye L","year":"2019","unstructured":"Ye L, Shipley E, Lippmann S. Transdermal clonidine for mitigating posttraumatic stress disorder in an adolescent. Am J Health Syst Pharm. 2019, 76:487-8. 10.1093\/ajhp\/zxz021","journal-title":"Am J Health Syst Pharm"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1097\/00004583-199608000-00006","article-title":"Guanfacine for PTSD nightmares","volume":"35","author":"Horrigan JP","year":"1996","unstructured":"Horrigan JP. Guanfacine for PTSD nightmares. J Am Acad Child Adolesc Psychiatry. 1996, 35:975-6. 10.1097\/00004583-199608000-00006","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1097\/CHI.0b013e318191769e","article-title":"Guanfacine extended release in children and adolescents with attention-deficit\/hyperactivity disorder: a placebo-controlled trial","volume":"48","author":"Sallee FR","year":"2009","unstructured":"Sallee FR, McGough J, Wigal T, Donahue J, Lyne A, Biederman J. Guanfacine extended release in children and adolescents with attention-deficit\/hyperactivity disorder: a placebo-controlled trial. J Am Acad Child Adolesc Psychiatry. 2009, 48:155-65. 10.1097\/CHI.0b013e318191769e","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"ref38","article-title":"A placebo-controlled trial of guanfacine for the treatment of posttraumatic stress disorder in veterans","volume":"41","author":"Davis LL","year":"2008","unstructured":"Davis LL, Ward C, Rasmusson A, Newell JM, Frazier E, Southwick SM. A placebo-controlled trial of guanfacine for the treatment of posttraumatic stress disorder in veterans. Psychopharmacol Bull. 2008, 41:8-18.","journal-title":"Psychopharmacol Bull"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.163.12.2186","article-title":"No improvement of posttraumatic stress disorder symptoms with guanfacine treatment","volume":"163","author":"Neylan TC","year":"2006","unstructured":"Neylan TC, Lenoci M, Samuelson KW, et al.. No improvement of posttraumatic stress disorder symptoms with guanfacine treatment. Am J Psychiatry. 2006, 163:2186-8. 10.1176\/appi.ajp.163.12.2186","journal-title":"Am J Psychiatry"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1097\/00005053-198909000-00005","article-title":"Clonidine in Cambodian patients with posttraumatic stress disorder","volume":"177","author":"Kinzie JD","year":"1989","unstructured":"Kinzie JD, Leung P. Clonidine in Cambodian patients with posttraumatic stress disorder. J Nerv Ment Dis. 1989, 177:546-50. 10.1097\/00005053-198909000-00005","journal-title":"J Nerv Ment Dis"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1097\/00005053-199410000-00010","article-title":"The polysomnographic effects of clonidine on sleep disorders in posttraumatic stress disorder: a pilot study with Cambodian patients","volume":"182","author":"Kinzie JD","year":"1994","unstructured":"Kinzie JD, Sack RL, Riley CM. The polysomnographic effects of clonidine on sleep disorders in posttraumatic stress disorder: a pilot study with Cambodian patients. J Nerv Ment Dis. 1994, 182:585-7. 10.1097\/00005053-199410000-00010","journal-title":"J Nerv Ment Dis"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.3390\/jcm5120117","article-title":"Treatment of post-traumatic stress disorder nightmares at a Veterans Affairs Medical Center","volume":"5","author":"Detweiler MB","year":"2016","unstructured":"Detweiler MB, Pagadala B, Candelario J, Boyle JS, Detweiler JG, Lutgens BW. Treatment of post-traumatic stress disorder nightmares at a Veterans Affairs Medical Center. J Clin Med. 2016, 5:117. 10.3390\/jcm5120117","journal-title":"J Clin Med"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2014.09.014","article-title":"Efficacy and safety of extended-release guanfacine hydrochloride in children and adolescents with attention-deficit\/hyperactivity disorder: a randomized, controlled, phase III trial","volume":"24","author":"Hervas A","year":"2014","unstructured":"Hervas A, Huss M, Johnson M, et al.. Efficacy and safety of extended-release guanfacine hydrochloride in children and adolescents with attention-deficit\/hyperactivity disorder: a randomized, controlled, phase III trial. Eur Neuropsychopharmacol. 2014, 24:1861-72. 10.1016\/j.euroneuro.2014.09.014","journal-title":"Eur Neuropsychopharmacol"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1097\/00004583-199501000-00013","article-title":"An open trial of guanfacine in the treatment of attention-deficit hyperactivity disorder","volume":"34","author":"Hunt RD","year":"1995","unstructured":"Hunt RD, Arnsten AF, Asbell MD. An open trial of guanfacine in the treatment of attention-deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 1995, 34:50-4. 10.1097\/00004583-199501000-00013","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1038\/s41386-018-0039-3","article-title":"A randomized, placebo-controlled trial of extended-release guanfacine in children with autism spectrum disorder and ADHD symptoms: an analysis of secondary outcome measures","volume":"43","author":"Politte LC","year":"2018","unstructured":"Politte LC, Scahill L, Figueroa J, McCracken JT, King B, McDougle CJ. A randomized, placebo-controlled trial of extended-release guanfacine in children with autism spectrum disorder and ADHD symptoms: an analysis of secondary outcome measures. Neuropsychopharmacology. 2018, 43:1772-8. 10.1038\/s41386-018-0039-3","journal-title":"Neuropsychopharmacology"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1503\/jpn.180039","article-title":"Managing disruptive behaviour in autism-spectrum disorder with guanfacine","volume":"43","author":"Propper L","year":"2018","unstructured":"Propper L. Managing disruptive behaviour in autism-spectrum disorder with guanfacine. J Psychiatry Neurosci. 2018, 43:359-60. 10.1503\/jpn.180039","journal-title":"J Psychiatry Neurosci"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.4088\/jcp.v65n1018","article-title":"Clonidine in acute aversive inner tension and self-injurious behavior in female patients with borderline personality disorder","volume":"65","author":"Philipsen A","year":"2004","unstructured":"Philipsen A, Richter H, Schmahl C, Peters J, R\u00fcsch N, Bohus M, Lieb K. Clonidine in acute aversive inner tension and self-injurious behavior in female patients with borderline personality disorder. J Clin Psychiatry. 2004, 65:1414-19. 10.4088\/jcp.v65n1018","journal-title":"J Clin Psychiatry"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1979.tb00897.x","article-title":"Clonidine withdrawal. Mechanism and frequency of rebound hypertension","volume":"7","author":"Geyskes GG","year":"1979","unstructured":"Geyskes GG, Boer P, Dorhout Mees EJ. Clonidine withdrawal. Mechanism and frequency of rebound hypertension. Br J Clin Pharmacol. 1979, 7:55-62. 10.1111\/j.1365-2125.1979.tb00897.x","journal-title":"Br J Clin Pharmacol"},{"key":"ref49","article-title":"","author":"Connor DF","year":"2006","unstructured":"Connor DF, Meltzer BM. Pediatric Psychopharmacology: Fast Facts. W.W. Norton & Co, New York; 2006. https:\/\/psycnet.apa.org\/record\/2006-01561-000."},{"key":"ref50","article-title":"Clonidine","author":"Yasaei R","year":"2023","unstructured":"Yasaei R, Saadabadi A. Clonidine. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2023."},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1097\/00004583-199506000-00008","article-title":"Carbamazepine for PTSD","volume":"34","author":"Looff D","year":"1995","unstructured":"Looff D, Grimley P, Kuller F, Martin A, Shonfield L. Carbamazepine for PTSD. J Am Acad Child Adolesc Psychiatry. 1995, 34:703-4. 10.1097\/00004583-199506000-00008","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-9338(15)31186-X","article-title":"Fluoxetine in the treatment of children with PTSD","volume":"30","author":"Martsenkovsky I","year":"2015","unstructured":"Martsenkovsky I, Martsenkovska I, Martsenkovsky D. Fluoxetine in the treatment of children with PTSD. European Psychiatry. 2015, 30:1537. 10.1016\/S0924-9338(15)31186-X","journal-title":"European Psychiatry"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1038\/nrn3339","article-title":"Biological studies of post-traumatic stress disorder","volume":"13","author":"Pitman RK","year":"2012","unstructured":"Pitman RK, Rasmusson AM, Koenen KC, et al.. Biological studies of post-traumatic stress disorder. Nat Rev Neurosci. 2012, 13:769-87. 10.1038\/nrn3339","journal-title":"Nat Rev Neurosci"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1016\/s0006-3223(00)00828-3","article-title":"Exaggerated amygdala response to masked facial stimuli in posttraumatic stress disorder: a functional MRI study","volume":"47","author":"Rauch SL","year":"2000","unstructured":"Rauch SL, Whalen PJ, Shin LM, et al.. Exaggerated amygdala response to masked facial stimuli in posttraumatic stress disorder: a functional MRI study. Biol Psychiatry. 2000, 47:769-76. 10.1016\/s0006-3223(00)00828-3","journal-title":"Biol Psychiatry"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.2165\/11537790-000000000-00000","article-title":"Effects of guanfacine extended release on oppositional symptoms in children aged 6-12 years with attention-deficit hyperactivity disorder and oppositional symptoms: a randomized, double-blind, placebo-controlled trial","volume":"24","author":"Connor DF","year":"2010","unstructured":"Connor DF, Findling RL, Kollins SH, Sallee F, L\u00f3pez FA, Lyne A, Tremblay G. Effects of guanfacine extended release on oppositional symptoms in children aged 6-12 years with attention-deficit hyperactivity disorder and oppositional symptoms: a randomized, double-blind, placebo-controlled trial. CNS Drugs. 2010, 24:755-68. 10.2165\/11537790-000000000-00000","journal-title":"CNS Drugs"},{"key":"ref56","article-title":"Risperidone and PTSD in boys","volume":"11","author":"Horrigan JP","year":"1999","unstructured":"Horrigan JP, Barnhill LJ. Risperidone and PTSD in boys. J Neuropsychiatry Clin Neurosci. 1999, 11:126-27.","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2009.06.026","article-title":"Neurobiological basis of failure to recall extinction memory in posttraumatic stress disorder","volume":"66","author":"Milad MR","year":"2009","unstructured":"Milad MR, Pitman RK, Ellis CB, et al.. Neurobiological basis of failure to recall extinction memory in posttraumatic stress disorder. Biol Psychiatry. 2009, 66:1075-82. 10.1016\/j.biopsych.2009.06.026","journal-title":"Biol Psychiatry"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/211807-alpha-2-agonists-in-children-and-adolescents-with-post-traumatic-stress-disorder-a-systematic-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:14:09Z","timestamp":1707509649000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/211807-alpha-2-agonists-in-children-and-adolescents-with-post-traumatic-stress-disorder-a-systematic-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,26]]},"references-count":57,"URL":"https:\/\/doi.org\/10.7759\/cureus.53009","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1,26]]}}}